BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 38540761)

  • 1. Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling.
    Liu H; Li X; Shi Y; Ye Z; Cheng X
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.
    Rubio T; Köhn M
    Biochem Soc Trans; 2016 Oct; 44(5):1305-1312. PubMed ID: 27911713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL-3 phosphatase and cancer metastasis.
    Al-Aidaroos AQ; Zeng Q
    J Cell Biochem; 2010 Dec; 111(5):1087-98. PubMed ID: 21053359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting phosphatases of regenerating liver (PRLs) in cancer.
    Wei M; Korotkov KV; Blackburn JS
    Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo.
    Song R; Qian F; Li YP; Sheng X; Cao SX; Xu Q
    PLoS One; 2009; 4(2):e4450. PubMed ID: 19214221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells.
    Al-Aidaroos AQ; Yuen HF; Guo K; Zhang SD; Chung TH; Chng WJ; Zeng Q
    J Clin Invest; 2013 Aug; 123(8):3459-71. PubMed ID: 23867504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion.
    Yang Y; Lian S; Meng L; Qu L; Shou C
    PLoS One; 2017; 12(1):e0169665. PubMed ID: 28068414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.
    Peng L; Xing X; Li W; Qu L; Meng L; Lian S; Jiang B; Wu J; Shou C
    Mol Cancer; 2009 Nov; 8():110. PubMed ID: 19930715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.
    Wang Y; Lazo JS
    Oncogene; 2012 Feb; 31(7):818-27. PubMed ID: 21765462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and oncogenic roles of the PRL phosphatases.
    Hardy S; Kostantin E; Hatzihristidis T; Zolotarov Y; Uetani N; Tremblay ML
    FEBS J; 2018 Nov; 285(21):3886-3908. PubMed ID: 29770564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-Regulation of Phosphatase in Regenerating Liver-3 (PRL-3) Contributes to Malignant Progression of Hepatocellular Carcinoma by Activating Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN)/Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway.
    Li BH; Wang Y; Wang CY; Zhao MJ; Deng T; Ren XQ
    Med Sci Monit; 2018 Nov; 24():8105-8114. PubMed ID: 30418964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.
    Gao PP; Qi XW; Sun N; Sun YY; Zhang Y; Tan XN; Ding J; Han F; Zhang Y
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188562. PubMed ID: 33964330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatase and Pseudo-Phosphatase Functions of Phosphatase of Regenerating Liver 3 (PRL-3) Are Insensitive to Divalent Metals In Vitro.
    Jolly JT; Cheatham TC; Blackburn JS
    ACS Omega; 2023 Aug; 8(33):30578-30589. PubMed ID: 37636930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.
    Basak S; Jacobs SB; Krieg AJ; Pathak N; Zeng Q; Kaldis P; Giaccia AJ; Attardi LD
    Mol Cell; 2008 May; 30(3):303-14. PubMed ID: 18471976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRL PTPs: mediators and markers of cancer progression.
    Bessette DC; Qiu D; Pallen CJ
    Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
    Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
    Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.
    Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J
    J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.
    Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity.
    Han YM; Lee SK; Jeong DG; Ryu SE; Han DC; Kim DK; Kwon BM
    Bioorg Med Chem Lett; 2012 Jan; 22(1):323-6. PubMed ID: 22137788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.